(PM) Philip Morris International - Ratings and Ratios

Philip Morris International Inc. (NYSE:PM) is a leading global tobacco and nicotine products company, operating in over 180 countries. The company specializes in cigarettes, smoke-free products, and wellness solutions. Its product portfolio includes IQOS heat-not-burn devices, ZYN oral nicotine products, and a range of Marlboro, Chesterfield, and L&M cigarette brands. PM also manufactures consumer accessories like lighters and matches. The company has been expanding into wellness and healthcare products as part of its strategic shift toward reduced-risk offerings.

Headquartered in Stamford, Connecticut, Philip Morris International was incorporated in 1987 as a spin-off from Philip Morris Companies Inc. The company has been actively transitioning its business model to focus on smoke-free alternatives, aiming to achieve a smoke-free future. This strategy includes significant investments in research and development for innovative nicotine delivery systems.

From a technical perspective, PMs stock shows a bullish trend, with its 20-day Simple Moving Average (SMA) of 155.21 surpassing the 50-day SMA of 152.49. The stock is trading above its 200-day SMA of 127.48, indicating long-term upward momentum. The Average True Range (ATR) of 3.90 suggests moderate volatility. The stocks last price of 163.21 reflects strong market sentiment.

Fundamentally, PM has a market capitalization of $245.287 billion, positioning it as a large-cap company. The trailing P/E ratio of 26.27 and forward P/E of 22.22 indicate a premium valuation, reflecting investor confidence in its growth prospects. The price-to-sales ratio of 6.48 is elevated, suggesting a strong revenue multiple. However, the return on equity (RoE) of -60.06% raises concerns about profitability, potentially linked to strategic investments in smoke-free products and restructuring efforts.

3-Month Forecast: Based on the convergence of and , PM is expected to maintain its upward trajectory in the near term. The stocks technical indicators, such as the rising SMA levels, suggest continued bullish momentum. However, the elevated P/E ratio and negative RoE may lead to short-term volatility. The companys focus on smoke-free products and its strong market position are likely to support its valuation. Investors should monitor the companys progress in achieving its smoke-free targets and its ability to improve profitability.